Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
#Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity #ESCCongress STEP-HFpEF trial Yes Dr
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1)
Antispasmodics can help alleviate abdominal pain and discomfort, while some patients may benefit from low-dose antidepressants to address the gut-brain axis component of the disorder
Sony Sherpa completed her MBBS at Guangzhou Medical University, China
Contributions of the microbial hydrogen economy to colonic homeostasis
US$ 25.84
US$ 21.75
